Skip to Main Content

Paper Details

Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
Inflamm Bowel Dis
66
2022
1273, COVID, COVID-19, IBD, Inflammatory Bowel Disease, Injection site tenderness, SARS-CoV-2, Severe acute respiratory syndrome, antitumor necrosis factor, coronavirus 2, coronavirus disease, fatigue, inflammatory bowel disease, mRNA, participants, patients, severe acute respiratory syndrome
Author NameAffiliation
Marla C DubinskyIcahn School of Medicine at Mount Sinai
Athos BousvarosBoston Children's Hospital
  • 1 - 2

Datasets

Release 1.2